Patricia Ann Mosconi - 05 Mar 2026 Form 4 Insider Report for BROADRIDGE FINANCIAL SOLUTIONS, INC. (BR)

Reporting relationship: Director
Issuer ticker: BR
Reported as of: 05 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Mar 2026, 13:39:29 UTC
Prior SEC filing: 18 Feb 2026
Next SEC filing: 09 Apr 2026
Source filing: View source filing
Reporting owner signature: Maria Allen, Power of Attorney

Key filing fact

Patricia Ann Mosconi filed Form 4 for BROADRIDGE FINANCIAL SOLUTIONS, INC. (BR) on 06 Mar 2026.

Key facts

This page summarizes Patricia Ann Mosconi's Form 4 filing for BROADRIDGE FINANCIAL SOLUTIONS, INC. (BR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 06 Mar 2026, 13:39.

Change

Previous filing in this sequence was filed on 18 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111349 Primary reporting owner

Mosconi Patricia Ann

Relationship: Director
Address: C/O BROADRIDGE FINANCIAL SOLUTIONS, INC., 5 DAKOTA DRIVE, LAKE SUCCESS
Signature: Maria Allen, Power of Attorney
Signature date: 06 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BR transaction

Common Stock

Award

Transaction value
Shares: +420
Change %: +4200%
Price: $0.000000^*
Shares after: 430
Date: 05 Mar 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares: +1,786
Change %
Price: $0.000000^*
Shares after: 1,786
Date: 05 Mar 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,786
Exercise price: $190.89
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported transaction reflects the grant of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan and represents a like number of shares of Broadridge common stock. The Deferred Stock Units vest in full upon grant and will settle in shares of Broadridge common stock upon the director's separation from service with Broadridge.

Footnote F2

Stock options vest immediately upon grant.